Publication
Survival of recurrent/metastatic head and neck squamous cell cancer (r/mHNSCC) patients (pts) treated in 1st or 2nd line with an anti-EGFR-antibody (EAB)
Presentation - Oct 10, 2015
Siano Marco
Units
Contact
Citation
Siano M (2015). Survival of recurrent/metastatic head and neck squamous cell cancer (r/mHNSCC) patients (pts) treated in 1st or 2nd line with an anti-EGFR-antibody (EAB). Presented at: DGHO 2015, Basel
Type
Presentation (Deutsch)
Event Name
DGHO 2015 (Basel)
Publication Date
Oct 10, 2015
Brief description/objective
Siano M, Desax MC, Früh M, Jörger M. Survival of recurrent/metastatic head and neck squamous cell cancer (r/mHNSCC) patients (pts) treated in 1st or 2nd line with an anti-EGFR-antibody (EAB). Oncol Res Treat 2015;38(suppl 5):186. abstract V614.